BioCentury
ARTICLE | Clinical News

KSB to start osteoarthritis Phase IIb

February 9, 2001 8:00 AM UTC

KS Biomedix (LSE:KSB) will begin this quarter European Phase IIb testing of its KSB301 (CB-2431) in 400 osteoarthritis patients. The product modulates the leakage of MAO into the cytoplasm of chondroc...